Incorporating Surgery in treatment of Stage IIIA – N2 Non- Small Cell Lung Cancer

Authors

  • Binay Thakur Thoracic Surgery Unit, Department of Surgical Oncology. B.P. Koirala Memorial Cancer Hospital, Bharatpur, Nepal
  • Mukti Devkota Thoracic Surgery Unit, Department of Surgical Oncology. B.P. Koirala Memorial Cancer Hospital, Bharatpur, Nepal

DOI:

https://doi.org/10.3126/njc.v5i1.41369

Keywords:

neoadjuvant treatment, non-small cell lung cancer, surgery, stage IIIA (N2)

Abstract

Stage IIIA-N2 Non-small cell lung cancer includes heterogenous group of patients with a poor 5-year survival ranging from 13% to 36% with surgery alone. Various randomized controlled trials established the role of multimodality treatment either including or excluding surgical resection. In a select group of non-bulky/ single station N2 disease, the better results have been achieved with induction chemotherapy or chemo-radiotherapy followed by surgery. 

Downloads

Download data is not yet available.
Abstract
103
PDF
128

Downloads

Published

2021-09-26

How to Cite

Thakur, B., & Devkota, M. (2021). Incorporating Surgery in treatment of Stage IIIA – N2 Non- Small Cell Lung Cancer. Nepalese Journal of Cancer, 5(1), 33–43. https://doi.org/10.3126/njc.v5i1.41369

Issue

Vol. 5 No. 1 (2021)

Section

Review Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as NJC and the authors are acknowledged.

Submission of the manuscript means that the authors agree to assign exclusive copyright to NJC. The aim of NJC is to increase the visibility and ease of use of open access scientific and scholarly articles thereby promoting their increased usage and impact.